HK Stock Market Move | SHANDONG XINHUA (00719) opens more than 4% higher. The flu season has entered a peak period, and sales of anti-flu medications continue to increase.

SHANDONG XINHUA (00719) opened more than 4% higher and rose 4.01% to HKD 6.23 as of the time of writing, with a trading volume of HKD 2.3923 million. On the news front, according to the latest data from the Chinese Center for Disease Control and Prevention, the positive rate of influenza viruses is continuing to rise, with over 99% being H1N1. Health authorities in many regions across the country are urgently reminding the public to take personal protective measures and to guard against respiratory and intestinal infectious diseases. As the number of influenza infections increases, the sales of anti-influenza drugs have also been on the rise recently. Public information shows that Shandong Xinhua Pharmaceutical is a leading global supplier of antipyretic and analgesic drugs, including products such as ibuprofen, aspirin, Wuan series, and meloxicam.